| NCT ID | NCT04924998 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine |
| Condition | Immunoglobulin Light Amyloidosis Cardiomyopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2021-06-01 |
| Primary Completion | 2031-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2021-06-01 with a primary completion date of 2031-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study, patients diagnosed with Al-CM were selected to observe the effect of treatment and conduct long-term follow-up.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18-90 years, regardless of gender, diagnosed with Al-CM at the Second Affiliated Hospital of Zhejiang University School of Medicine; * Patients have the ability to understand the test, can cooperate with investigators. Exclusion Criteria: * Unable to understand or unwilling to fill in informed consent forms or follow visitors
Frequently Asked Questions
Who can join the NCT04924998 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Immunoglobulin Light Amyloidosis Cardiomyopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04924998 currently recruiting?
Yes, NCT04924998 is actively recruiting participants. Visit ClinicalTrials.gov or contact Second Affiliated Hospital, Zhejiang University, School of Medicine to inquire about joining.
Where is the NCT04924998 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT04924998 clinical trial?
NCT04924998 is sponsored by Second Affiliated Hospital, Zhejiang University, School of Medicine. The trial plans to enroll 400 participants.